173 related articles for article (PubMed ID: 4613977)
1. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
Waters MF; Rees RJ; McDougall AC; Weddell AG
Lepr Rev; 1974 Dec; 45(4):288-98. PubMed ID: 4613977
[No Abstract] [Full Text] [Related]
2. Lepromatous leprosy in the nose after one year of dapsone treatment: clinical and bacteriological findings.
Barton RP; Hogerzeil LM
Lepr Rev; 1975 Dec; 46(4):257-65. PubMed ID: 1107725
[No Abstract] [Full Text] [Related]
3. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
4. The histopathology of lepromatous leprosy in the nose.
McDougall AC; Rees RJ; Weddell AG; Kanan MW
J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
[TBL] [Abstract][Full Text] [Related]
5. The continuous bacteremia of lepromatous leprosy.
Drutz DJ; Chen TS; Lu WH
N Engl J Med; 1972 Jul; 287(4):159-64. PubMed ID: 4555967
[No Abstract] [Full Text] [Related]
6. Lepromatous leprosy in the nose after one year of dapsone treatment: histopathological findings.
McDougall AC; Weddell AG; Rees RJ
Lepr Rev; 1975 Dec; 46(4):267-77. PubMed ID: 1107726
[No Abstract] [Full Text] [Related]
7. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
8. Pathologic changes in the soft palate in lepromatous leprosy. An evaluation of ten patients.
Reichart P
Oral Surg Oral Med Oral Pathol; 1974 Dec; 38(6):898-904. PubMed ID: 4614162
[No Abstract] [Full Text] [Related]
9. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
10. Low dose dapsone therapy in lepromatous leprosy.
Karat AB
Lepr Rev; 1975 Jun; 46(2 Suppl):89-92. PubMed ID: 1100970
[No Abstract] [Full Text] [Related]
11. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
Pearson JM; Pettit JH
Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
[No Abstract] [Full Text] [Related]
12. Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae.
McDougall AC; Rees RJ
Lepr Rev; 1973 Jun; 44(2):59-64. PubMed ID: 4582180
[No Abstract] [Full Text] [Related]
13. A statistical analysis of two chemotherapy trials in lepromatous leprosy. II. Interactions among patient variables.
Am J Trop Med Hyg; 1978 Sep; 27(5):1015-8. PubMed ID: 362951
[TBL] [Abstract][Full Text] [Related]
14. Presence of Mycobacterium leprae in epidermal cells of lepromatous skin and its significance.
Satapathy J; Kar BR; Job CK
Indian J Dermatol Venereol Leprol; 2005; 71(4):267-9. PubMed ID: 16394437
[TBL] [Abstract][Full Text] [Related]
15. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
[No Abstract] [Full Text] [Related]
16. Bacillaemia in leprosy and effect of multidrug therapy.
Chatterjee G; Kaur S; Sharma VK; Vaishnavi C; Ganguly NK
Lepr Rev; 1989 Sep; 60(3):197-201. PubMed ID: 2682105
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
Languillon J; Yawalkar SJ; McDougall AC
Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
[No Abstract] [Full Text] [Related]
18. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
Koticha KK; Sane AB
Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
[No Abstract] [Full Text] [Related]
19. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
20. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
